2011, Blood Pressure and DEA - Medical Cannabis Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2011

Blood Pressure

DEA

Chacruna: Ayahuasca FOIA Requests Reveal Increased Ayahuasca Seizures, Lack of Due Process and Government Secrecy

Cannabis Law Report

JUNE 28, 2021

Drug Enforcement Agency (“DEA”). 562 [2011]). While CBP has at least provided some response to the initial request, DEA has completely stonewalled the Initiative to date. While CBP has at least provided some response to the initial request, DEA has completely stonewalled the Initiative to date. Best, [name redacted].

DEA

DEA Blood Pressure Safety Policy

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Cannabis Law Report

SEPTEMBER 23, 2019

33 Adults and adolescents may experience increased blood pressure and respiratory rates, red eyes, dry mouth, increased appetite, and slurred speech. 5 In 1970, the DEA classified marijuana as a Schedule I drug, which is defined as a drug with no current acceptable medical use and a high potential for abuse. N Engl J Med.

Cannabinoids

Cannabinoids Marijuana Research and Development Access

Chacruna: Ayahuasca FOIA Requests Reveal Increased Ayahuasca Seizures, Lack of Due Process and Government Secrecy

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Stay Connected